Alberton Acquisition Corporation (NASDAQ:ALAC) and ARYA Sciences Acquisition Corp. (NASDAQ:ARYAU), both competing one another are Conglomerates companies. We will compare their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alberton Acquisition Corporation | 10 | 0.00 | N/A | 0.02 | 436.96 |
| ARYA Sciences Acquisition Corp. | 10 | 0.00 | N/A | 0.00 | 0.00 |
Demonstrates Alberton Acquisition Corporation and ARYA Sciences Acquisition Corp. earnings per share, gross revenue and valuation.
Profitability
Table 2 provides Alberton Acquisition Corporation and ARYA Sciences Acquisition Corp.’s return on equity, return on assets and net margins.
| Net Margins | Return on Equity | Return on Assets | |
| Alberton Acquisition Corporation | 0.00% | 0% | 0% |
| ARYA Sciences Acquisition Corp. | 0.00% | 0% | 0% |
Institutional & Insider Ownership
The shares of both Alberton Acquisition Corporation and ARYA Sciences Acquisition Corp. are owned by institutional investors at 44.57% and 56.9% respectively. Insiders held 17.82% of Alberton Acquisition Corporation shares.
Performance
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
| Performance (W) | Performance (M) | Performance (Q) | Performance (HY) | Performance (Y) | Performance (YTD) | |
| Alberton Acquisition Corporation | 0.5% | 0.7% | 3.08% | 0% | 0% | 2.55% |
| ARYA Sciences Acquisition Corp. | 0.09% | 1.22% | 2.13% | 0% | 0% | 2.13% |
For the past year Alberton Acquisition Corporation was more bullish than ARYA Sciences Acquisition Corp.
Summary
Alberton Acquisition Corporation beats on 3 of the 4 factors ARYA Sciences Acquisition Corp.
ARYA Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the life sciences and medical technology sectors in North America and Europe. The company was incorporated in 2018 and is based in New York, New York.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
